Targeted delivery and stimulus-responsive release of anticancer drugs for efficient chemotherapy
Chemotherapy is currently an irreplaceable strategy for cancer treatment. Doxorubicin hydrochloride (DOX) is a clinical first-line drug for cancer chemotherapy. While its efficacy for cancer treatment is greatly compromised due to invalid enrichment or serious side effects. To increase the content o...
Main Authors: | Lei Qiao, Xue Yuan, Hui Peng, Guisong Shan, Min Gao, Xiaoqing Yi, Xiaoyan He |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2021.1986602 |
Similar Items
-
Sequential Drug Delivery in Targeted Cancer Therapy
by: Han Yu, et al.
Published: (2022-03-01) -
Active Targeting Gold Nanoparticle for Chemotherapy Drug Delivery: A Review
by: Azhoma Gumala, et al.
Published: (2022-07-01) -
Hierarchical pulmonary target nanoparticles via inhaled administration for anticancer drug delivery
by: Rui Chen, et al.
Published: (2017-01-01) -
Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy
by: Shan-Shan Qi, et al.
Published: (2017-01-01) -
Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood–Brain Barrier to Treat Brain Tumors
by: Wouter J. F. Vanbilloen, et al.
Published: (2023-06-01)